Dai-ichi Life Insurance Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Sell |
10,859
-29,853
| -73% | -$3.75M | 0.04% | 317 |
|
|
2025
Q1 | $4.5M | Sell |
40,712
-952
| -2% | -$105K | 0.13% | 164 |
|
|
2024
Q4 | $5.69M | Sell |
41,664
-455
| -1% | -$62.1K | 0.16% | 146 |
|
|
2024
Q3 | $4.85M | Sell |
42,119
-6,358
| -13% | -$733K | 0.12% | 164 |
|
|
2024
Q2 | $6.67M | Buy |
48,477
+27,529
| +131% | +$3.79M | 0.16% | 139 |
|
|
2024
Q1 | $2.89M | Buy |
+20,948
| New | +$2.89M | 0.07% | 254 |
|
|
2017
Q1 | – | Sell |
-16,677
| Closed | -$645K | – | 563 |
|
|
2016
Q4 | $645K | Buy |
+16,677
| New | +$645K | 0.02% | 433 |
|